Diazine derivatives

Details Diazine derivatives Diazine derivatives

2007-02-20

2007-02-20

Habte, Kansay (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C544S238000, C544S316000, C544S318000, C544S319000, C544S405000, C514S255050, C514S274000

Reexamination Certificate

active

11096286

ABSTRACT:
The present invention provides compounds of formula (I):their pharmaceutically acceptable salts or esters, enantiomeric forms, diastereoisomers and racemates, the preparation of the above-mentioned compounds, pharmaceutical compositions containing them and their manufacture, as well as the use of the above-mentioned compounds in the control or prevention of illnesses such as cancer.

REFERENCES:
patent: 2003/0069419 (2003-04-01), Ikemoto et al.
patent: 1270571 (2003-01-01), None
patent: WO 98/03505 (1998-01-01), None
patent: WO 01/77107 (2001-10-01), None
patent: WO 03/031442 (2003-04-01), None
patent: WO 03/059907 (2003-07-01), None
patent: WO 03/091247 (2003-11-01), None
Wilks et al., Progress in Growth Factor Research, 2, pp. 97-111 (1990).
Chan et a., Cur. Opin. in Immunol., 8, pp. 394-401 (1995).
Yarden et al., Ann. Rev. Biochem., 57, pp. 443-478 (1988).
Wright et al., Br. J. Cancer, 65, pp. 118-121 (1992).
Baselga et al., Oncology, 63 (Suppl. 1), pp. 6-16 (2002).
Ranson et al., Oncology, 63 (Suppl. 1), pp. 17-24 (2002).
Bastin et al., Organic Proc. Res. Dev., 4, pp. 427-435 (2000).

Affiliated with

Also associated with

Rating

Diazine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Diazine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diazine derivatives will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3892076